Knoll Capital Management, LLC Aldeyra Therapeutics, Inc. Transaction History

Knoll Capital Management, LLC

$160 Million
Q1 2024

A detailed history of Knoll Capital Management, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 5,475,516 shares of ALDX stock, worth $18.1 Million. This represents 11.18% of its overall portfolio holdings.

Number of Shares

5,475,516

Previous 5,475,516 -0.0%

Holding current value

$18.1 Million

Previous $19.2 Million 6.84%

% of portfolio

11.18%

Previous 15.97%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.47 - $6.06 $3.59 Million - $14.8 Million	2,443,601 Added 80.6%	5,475,516 $19.2 Million
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $99,269 - $132,575	16,247 Added 0.54%	3,031,915 $20.3 Million
Q2 2023 Aug 15, 2023	BUY	$7.11 - $11.89 $6.74 Million - $11.3 Million	948,508 Added 45.88%	3,015,668 $25.3 Million
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $687,033 - $1.18 Million	119,070 Added 6.11%	2,067,160 $20.5 Million
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $359,587 - $501,865	70,785 Added 3.77%	1,948,090 $13.6 Million

Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $1.42 Million - $2.9 Million	374,845 Added 24.95%	1,877,305 $10 Million
Q2 2022 Aug 15, 2022	BUY	$2.43 - $4.85 $1.81 Million - $3.6 Million	743,055 Added 97.85%	1,502,460 $6 Million
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $665,000 - $1.83 Million	190,000 Added 33.37%	759,405 $3.04 Million
Q4 2019 Feb 14, 2020	BUY	$4.73 - $7.98 $178,969 - $301,939	37,837 Added 7.12%	569,405 $3.31 Million
Q3 2019 Nov 14, 2019	BUY	$4.41 - $6.12 $9,604 - $13,329	2,178 Added 0.41%	531,568 $2.8 Million
Q2 2019 Aug 14, 2019	BUY	$6.0 - $9.0 $271,764 - $407,646	45,294 Added 9.36%	529,390 $3.18 Million
Q3 2018 Nov 14, 2018	BUY	$6.8 - $14.35 $2.45 Million - $5.17 Million	360,000 Added 290.1%	484,096 $6.32 Million
Q3 2017 Nov 14, 2017	BUY	$3.9 - $10.8 $483,974 - $1.34 Million	124,096	124,096 $893,000

Others Institutions Holding ALDX

# of Institutions

106

Shares Held

35.4M

Call Options Held

104K

Put Options Held

88.1K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $193M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.

Account

Knoll Capital Management, LLC Aldeyra Therapeutics, Inc. Transaction History